Insider · CIK 0001782758
Phillips Courtney
Files at MAZE (Maze Therapeutics, Inc.). First filing Sep 4, 2026, latest Sep 4, 2026.
Phillips Courtney files SEC Form 4 as officer at MAZE (Maze Therapeutics, Inc.). Since Sep 4, 2026, Phillips Courtney has reported 0 open-market buys worth $0 and 1 open-market sell worth $105k, the latest filed on Sep 4, 2026.
A track record needs three past buys with six months of prices behind them; Phillips Courtney has 0, so none is measured yet.
The newest scored trade: sold $105k of MAZE on Sep 2, 2026, filed Sep 4, 2026, scored 50 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $105k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MAZE: Maze Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Maze Therapeutics, Inc. | $105k 3,993 shares | -36% | - |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | MAZE Maze Therapeutics, Inc. | SOpen-market sale Common Stock | -1,738 | $26.38 | $46k | 9,262 | 39 d ago |
| Sep 2, 2026 | MAZE Maze Therapeutics, Inc. | SOpen-market sale Common Stock | -243 | $27.12 | $6,590 | 9,019 | 39 d ago |
| Sep 3, 2026 | MAZE Maze Therapeutics, Inc. | SOpen-market sale Common Stock | -1,990 | $26.01 | $52k | 7,029 | 39 d ago |
| Sep 3, 2026 | MAZE Maze Therapeutics, Inc. | SOpen-market sale Common Stock | -22 | $25.78 | $567 | 7,007 | 39 d ago |
| Sep 1, 2026 | MAZE Maze Therapeutics, Inc. | MOption exercise Common Stock | +11,000 | $0.00 | $0 | 11,000 | 40 d ago |
| Sep 1, 2026 | MAZE Maze Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -11,000 | $0.00 | $0 | 11,000 | 40 d ago |
| Mar 2, 2026 | MAZE Maze Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +32,000 | $0.00 | $0 | 32,000 | Mar 3, 2026 |
| Mar 2, 2026 | MAZE Maze Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +16,000 | $0.00 | $0 | 16,000 | Mar 3, 2026 |
| Sep 22, 2025 | MAZE Maze Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +22,000 | $0.00 | $0 | 22,000 | Sep 24, 2025 |
Questions about Phillips Courtney
Answered from the filings on this page, as of the latest one.
Is Phillips Courtney buying or selling?
In the last 12 months Phillips Courtney reported 0 open-market buys worth $0 and 1 open-market sell worth $105k on SEC Form 4; the latest was sold $105k of MAZE on Sep 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Phillips Courtney's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Phillips Courtney has 0.
Where does Phillips Courtney file Form 4?
Phillips Courtney has filed Form 4 at MAZE (Maze Therapeutics, Inc.) as GC and Corp. Secretary. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.